2018 | | Off-label use of tocilizumab to treat non-juvenile idiopathic arthritis in pediatric rheumatic patients: a literature review | 김현아, 서창희, 정주양 |
2018 | | Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis | 서창희 |
2018 | | Effect of fenofibrate on uric acid level in patients with gout | 김현아, 서창희, 윤덕용, 정주양, 최영 |
2018 | | Comparison of biosimilar CT-P10 and innovator rituximab in patients with rheumatoid arthritis: a randomized controlled Phase 3 trial | 서창희 |
2018 | | Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still's disease | 김현아, 서창희, 손성향, 정주양 |
2018 | | Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease | 김현아, 서창희, 정주양 |
2017 | | Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease | 김현아, 서창희, 손성향, 정주양 |
2017 | | An update: current and prospective treatments for adult-onset Still’s disease | 김현아, 서창희 |
2017 | | Infection in systemic lupus erythematosus, similarities, and differences with lupus flare | 서창희, 정주양 |
2017 | | Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
2017 | | Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis | 부선주, 서창희 |
2017 | | The Correlation of CD206, CD209, and Disease Severity in Behcet's Disease with Arthritis | 김현아, 서창희, 손성향 |
2017 | | Trabecular bone score as a supplementary tool for the discrimination of osteoporotic fractures in postmenopausal women with rheumatoid arthritis | 김현아, 서창희, 정윤석, 정주양, 최용준 |
2017 | | The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis | 김현아, 서창희, 정주양 |
2017 | | Elevated circulating levels of the interferon-gamma-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still's disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
2017 | | Efficacy and Safety of Switching from Innovator Rituximab to Biosimilar CT-P10 Compared with Continued Treatment with CT-P10: Results of a 56-Week Open-Label Study in Patients with Rheumatoid Arthritis | 서창희 |
2017 | | Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial | 서창희 |
2017 | | Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus | 김현아, 서창희, 정주양 |
2017 | | Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab | 김현아, 서창희 |
2017 | | The role of 18F-fluorodeoxyglucose positron emission tomography in the assessment of disease activity of adult-onset Still's disease | 김현아, 서창희, 안영실, 정주양 |